Moze Cowper Brought in as Co-Counsel by Hausfeld in Foreign Exchange Antitrust Litigation

On March 10, 2016, Moze Cowper was brought in as co-counsel with Hausfeld and Scott + Scott to assist in the settlement of The Foreign Exchange Benchmark Rates Antitrust Litigation.  The complaint alleges that the world’s largest financial institutions conspired to manipulate prices paid in the $5.3-trillion-per-day foreign exchange market from 2003 to present. The case is currently pending before Judge Lorna G. Schofield in the United States District Court for the Southern District of New York.

On December 15, 2015, Judge Schofield granted plaintiffs’ motion to preliminarily approve nine settlements in the case. These settlements with Bank of America, Barclays, BNP Paribas, Citi, Goldman Sachs, HSBC, JPMorgan, RBS, and UBS recover more than $2 billion for the plaintiff class.

Mr. Cowper was brought in as an expert in European data privacy and international e-discovery in order to assist in the preliminary settlement approval process and help build a legitimization plan for the transfer of certain information sought by the plaintiffs that is also governed by data privacy laws abroad.

Mr. Cowper is a Senior Editor on the Sedona Conference’s publication: International Principles on Discovery, Disclosure & Data Protection: Best Practices, Recommendations & Principles for Addressing the Preservation Discovery of Protected Data in U.S. Litigation.  He has also authored numerous articles on international discovery and has been a faculty member for the Sedona Conference for over a decade.

Dr. Steven Wang’s Recent Study on IVC Filters

On April 5th, 2016, Dr. Steven Wang presented at the annual Society of Interventional Radiology in Vancouver, Canada. Dr. Wang is an interventional radiologist from Palo Alto, California and is affiliated with Kaiser Permanente. In a retrospective study involving 96 patients he sought to understand the prevalence of long-term (greater than 46 month) complications of both permanent and retrievable IVC filters (IVCFs).Screen Shot 2016-03-13 at 11.57.34 AM

The study looked at all inferior vena cava filters implanted in patients from January 2007 through December 2009 at multiple health care facilities across the United States. Dr. Wang then identified all patients who had imaging of the filter taken at four years or more after implantation.  Of those patients (96), he then evaluated the imaging to determine whether or not the IVC filter had malfunctioned.

After reviewing the data, the authors concluded that device complications at four or more years after implantation “are relatively common.”  They also found that the Cordis OptEase and Trapease IVC filters suffered fracture rates of 37.5% and 23.1%, respectively.

Cowper Law has filed over a dozen lawsuits against the manufacturers of IVC filters in the last month.  A growing body of scientific research indicates that the risks of IVC filter implantation far outweighs any benefits.  If you have been implanted with an IVC filter, please call us at 877.LAW.3707 so we can discuss filing a lawsuit on your behalf.